Supported in part by grant No. HD04612 to the Mental Retardation Research Center. Presented at the Fifty-ninth Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society, Ojai, California, October 1118, 1992.
- 1 June 1993
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 168 (6), 1864-1869
- https://doi.org/10.1016/0002-9378(93)90703-l
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- First‐trimester maternal serum human chorionic gonadotrophin as a marker for fetal chromosomal disordersPrenatal Diagnosis, 1992
- Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha‐fetoprotein, and agePrenatal Diagnosis, 1991
- First‐trimester maternal serum biochemical indicators in Down syndromePrenatal Diagnosis, 1990
- Maternal serum markers in screening for Down syndromeClinical Genetics, 1990
- Human chorionic gonadotropin levels in pregnancies with aneuploid fetusesPrenatal Diagnosis, 1989
- FIRST-TRIMESTER BIOCHEMICAL SCREENING FOR DOWN SYNDROMEThe Lancet, 1988
- Maternal serum screening for Down's syndrome in early pregnancy.BMJ, 1988
- Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalitiesPrenatal Diagnosis, 1987
- Alpha-fetoprotein concentrations in maternal serum: relation to race and body weight.Clinical Chemistry, 1983